Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 10/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid Ethyl Ester SCHEMBL7542173 | 0.96 | THRB (0.44) | THRBTSHRHPGDCHRM2CHRM4 | |
| Acrylic Acid Ethyl Ester SCHEMBL6761428 | 0.94 | THRB (0.43) | THRBTSHRHPGDCHRM2CHRM4 | |
| SCHEMBL1538397 | 0.92 | TSHR (0.44) | THRBTSHRHPGDCHRM2CHRM4 | |
| Acrylic Acid Ethyl Ester SCHEMBL27698745 | 0.90 | ALDH1A1 (0.42) | THRBTSHRHPGDCHRM2CHRM4 | |
| Methacrylic Acid SCHEMBL28076204 | 0.88 | TSHR (0.41) | THRBTSHRHPGDCHRM2CHRM4 | |
| SCHEMBL10597742 | 0.87 | THRB (0.56) | THRBTSHRCHRM2CHRM4CHRM5 | |
| Acrylic Acid Ethyl Ester SCHEMBL17044687 | 0.87 | TSHR (0.53) | THRBTSHRHPGDCHRM2CHRM4 | |
| SCHEMBL5965838 | 0.87 | TSHR (0.41) | THRBTSHRHPGDCHRM2CHRM4 | |
| SCHEMBL5998966 | 0.87 | TSHR (0.61) | THRBTSHRHPGDCHRM2CHRM4 | |
| SCHEMBL22441621 | 0.87 | TSHR (0.41) | THRBTSHRHPGDCHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114681324-B | Double-release dosage form capsule and preparation method, device and system thereof | 盖尔凯普科技有限公司 | 2024-05-03 | — | — | CN | disclosed |
| EP-3167936-B1 | COSMETIC METHOD FOR TREATING HUMAN PERSPIRATION USING PARTICLES OF AN EXPANDED AMORPHOUS MINERAL MATERIAL; COMPOSITIONS | OREAL (FR) | 2023-06-07 | — | — | EP | disclosed |
| CN-108969406-B | Cosmetic use of monounsaturated fatty acids or one of their salts and/or one of their esters or amides as deodorant active agent | 莱雅公司 | 2022-05-27 | — | — | CN | disclosed |
| US-11266583-B2 | Cosmetic method for treating human perspiration using particles of an expanded amorphous mineral material; compositions | L'OREAL (FR) | 2022-03-08 | — | — | US | disclosed |
| EP-2642974-B1 | PROCESS FOR TREATING PERSPIRATION USING A CARBONYL COMPOUND CAPABLE OF REACTING VIA THE MAILLARD REACTION | OREAL (FR) | 2021-05-19 | — | — | EP | disclosed |
| US-10966913-B2 | Cosmetic use of spiculisporic acid as a deodorant active agent | L'OREAL (FR) | 2021-04-06 | — | — | US | disclosed |
| EP-2925413-B1 | COSMETIC WATER-IN-OIL EMULSION IN AEROSOL FORM, COMPRISING AT LEAST ONE VINYL POLYMER CONTAINING AT LEAST ONE CARBOSILOXANE DENDRIMER-BASED UNIT, AT LEAST ONE OLEFIN COPOLYMER AND AT LEAST ONE ANTIPERSPIRANT ACTIVE AGENT | OREAL (FR) | 2019-07-03 | — | — | EP | disclosed |
| US-10307365-B2 | Cosmetic use of a geraniol-rich essential oil of Satureja montana as deodorant active agent | L'OREAL (FR) | 2019-06-04 | — | — | US | disclosed |
| EP-2906183-B1 | COSMETIC USE OF A MONOUNSATURATED FATTY ACID OR ONE OF ITS SALTS AND/OR OF ITS ESTERS OR AMIDES AS DEODORANT ACTIVE AGENT | OREAL (FR) | 2019-03-20 | — | — | EP | disclosed |
| EP-2988827-B1 | COSMETIC USE OF A GERANIOL-RICH ESSENTIAL OIL OF SATUREJA MONTANA AS DEODORANT ACTIVE AGENT | OREAL (FR) | 2019-01-30 | — | — | EP | disclosed |
| EP-2358444-A1 | COSMETIC METHOD FOR TREATING HUMAN PERSPIRATION USING PARTICLES OF AN EXPANDED AMORPHOUS MINERAL MATERIAL; COMPOSITIONS | L'Oréal (FR) | 2011-08-24 | — | — | EP | disclosed |
| WO-2011073438-A2 | COSMETIC METHOD FOR TREATING BODY ODOURS USING A BACTERIOCIN BASED COMPOSITION | L'OREAL (FR) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011073440-A2 | DEODORANT COMPOSITION BASED ON ANTIMICROBIAL PEPTIDES AND METHOD FOR TREATING BODY ODOUR | L'OREAL (FR) | 2011-06-23 | — | — | WO | disclosed |
| WO-2010054921-A1 | COSMETIC METHOD FOR TREATING HUMAN PERSPIRATION USING PARTICLES OF AN EXPANDED AMORPHOUS MINERAL MATERIAL; COMPOSITIONS | L'OREAL (FR) | 2010-05-20 | — | — | WO | disclosed |
| US-20070148113-A1 | Antiperspirant compositions comprising at least one dispersion of cationic colloidal silica particles, antiperspirant product, and cosmetic process for treating perspiration | L'OREAL S.A. (FR) | 2007-06-28 | — | — | US | disclosed |
| EP-1663515-A4 | POROUS CERAMIC FILTERS WITH CATALYST COATINGS | CORNING INC (US) | 2007-04-04 | — | — | EP | disclosed |
| EP-1663515-A2 | POROUS CERAMIC FILTERS WITH CATALYST COATINGS | CORNING INCORPORATED (US) | 2006-06-07 | — | — | EP | disclosed |
| WO-2005018790-A2 | POROUS CERAMIC FILTERS WITH CATALYST COATINGS | CORNING INCORPORATED (US) | 2005-03-03 | — | — | WO | disclosed |
| US-20050037147-A1 | Porous ceramic filters with catalyst coatings | CORNING INCORPORATED | 2005-02-17 | — | — | US | disclosed |
| EP-0003431-A1 | Production of carboxylic acid anhydrides and catalysts therefor | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1979-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10966913-B2 | Cosmetic use of spiculisporic acid as a deodorant active agent | DPM1, KRT18, TYR | THRB 2736/4885TSHR 2556/4885HPGD 1252/4885 |
| US-10307365-B2 | Cosmetic use of a geraniol-rich essential oil of Satureja montana as deodorant active agent | CUTA, DAGLA, KRT18 | THRB 395/4885TSHR 1965/4885HPGD 2007/4885 |
| US-11266583-B2 | Cosmetic method for treating human perspiration using particles of an expanded amorphous mineral material; compositions | CUTA, FABP4, SOST | THRB 3114/4885TSHR 2327/4885HPGD 3067/4885 |
| US-20070148113-A1 | Antiperspirant compositions comprising at least one dispersion of cationic colloidal silica particles, antiperspirant product, and cosmetic process for treating perspiration | TRPA1, CUTA, PIEZO1 | THRB 4635/4885TSHR 2474/4885HPGD 4463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.